Stephan Moll1, Elizabeth A Varga2. 1. From Hemophilia and Thrombosis Center and Clot Connect Program (www.clotconnect.org), University of North Carolina School of Medicine, Chapel Hill (S.M.); Division of Hematology/Oncology/Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH (E.A.V.); and The Ohio State University College of Medicine, Columbus (E.A.V.). smoll@med.unc.edu. 2. From Hemophilia and Thrombosis Center and Clot Connect Program (www.clotconnect.org), University of North Carolina School of Medicine, Chapel Hill (S.M.); Division of Hematology/Oncology/Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH (E.A.V.); and The Ohio State University College of Medicine, Columbus (E.A.V.).
Authors: Melissa R Meyer; Daniel M Witt; Thomas Delate; Samuel G Johnson; Margaret Fang; Alan Go; Nathan P Clark Journal: Thromb Res Date: 2015-10-21 Impact factor: 3.944
Authors: Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi Journal: Nat Rev Cardiol Date: 2019-01 Impact factor: 32.419
Authors: Anca Elena Gogu; Andrei Gheorghe Motoc; Alina Zorina Stroe; Any Docu Axelerad; Daniel Docu Axelerad; Ligia Petrica; Dragos Catalin Jianu Journal: Metabolites Date: 2021-04-23